The governance structure for data access in the DIRECT consortium: an innovative medicines initiative (IMI) project

Biomedical research projects involving multiple partners from public and private sectors require coherent internal governance mechanisms to engender good working relationships. The DIRECT project is an example of such a venture, funded by the Innovative Medicines Initiative Joint Undertaking (IMI JU...

Descripción completa

Detalles Bibliográficos
Autores principales: Teare, Harriet J. A., de Masi, Federico, Banasik, Karina, Barnett, Anna, Herrgard, Sanna, Jablonka, Bernd, Postma, Jacqueline W. M., McDonald, Timothy J., Forgie, Ian, Chmura, Piotr J., Rydzka, Emil K., Gupta, Ramneek, Brunak, Soren, Pearson, Ewan, Kaye, Jane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123336/
https://www.ncbi.nlm.nih.gov/pubmed/30182269
http://dx.doi.org/10.1186/s40504-018-0083-0
Descripción
Sumario:Biomedical research projects involving multiple partners from public and private sectors require coherent internal governance mechanisms to engender good working relationships. The DIRECT project is an example of such a venture, funded by the Innovative Medicines Initiative Joint Undertaking (IMI JU). This paper describes the data access policy that was developed within DIRECT to support data access and sharing, via the establishment of a 3-tiered Data Access Committee. The process was intended to allow quick access to data, whilst enabling strong oversight of how data were being accessed and by whom, and any subsequent analyses, to contribute to the overall objectives of the consortium.

Ejemplares similares